HUGE

FSD Pharma (HUGE)

FSD Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HUGE

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	20:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/05/28	21:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/05/25	05:51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/05/16	21:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/05/07	21:31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/03/11	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/03/05	22:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/28	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/26	22:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/20	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/20	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/08	06:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/02/08	05:56	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/01/16	21:38	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2024/01/12	03:10	GlobeNewswire Inc.	GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case	NASDAQ:HUGE	FSD Pharma Inc
2024/01/05	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:HUGE	FSD Pharma Inc
2023/12/26	20:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/22	06:17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/19	02:31	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:47	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/15	23:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/12/06	00:33	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/11/30	22:37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/11/28	23:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/11/27	21:48	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:HUGE	FSD Pharma Inc
2023/09/22	19:00	GlobeNewswire Inc.	InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington	NASDAQ:HUGE	FSD Pharma Inc